4967 — Kobayashi Pharmaceutical Co Share Price
0.000.00%
Last trade - 00:00- ¥452bn
- ¥401bn
- ¥173bn
- 90
- 31
- 54
- 64
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 26.65 | ||
| PEG Ratio (f) | 0.83 | ||
| EPS Growth (f) | 47.5% | ||
| Dividend Yield (f) | 1.71% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.21 | ||
| Price to Tang. Book | 2.44 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.68 | ||
| EV to EBITDA | 19.65 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.03% | ||
| Return on Equity | 4.86% | ||
| Operating Margin | 7.53% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 158,340 | 150,514 | 155,252 | 166,258 | 173,455 | 167,829 | 175,489 | 0.7% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +3.89 | -0.14 | +2 | +3.43 | +3.28 | -48.43 | +58.29 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
KOBAYASHI PHARMACEUTICAL CO., LTD. a drug manufacturer. The Company operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.
Directors
- Kazumasa Kobayashi CHM (80)
- Akihiro Kobayashi PRE (49)
- Noriaki Hirao FID
- Satoshi Yamane SMD (61)
- Naoki Ayabe MEO
- Fujito Ohwaki MEO
- Atsushi Sato DSL
- Jun Sato DSL
- Kazuhito Miyanishi EXO (58)
- Takuya Matsushita EXO
- Tetsushi Nishioka EXO
- Yoshihiro Ogawa EXO
- Nobuo Sakuta EXO
- Kunio Ito IND (69)
- Kaori Sasaki IND (61)
- Haruo Tsuji IND (88)
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- August 22nd, 1919
- Public Since
- April 20th, 1999
- No. of Shareholders
- 37,974
- No. of Employees
- 3,534
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 74,338,888
- Address
- KDX Kobayashi Doshomachi Bldg., OSAKA-SHI, 541-0045
- Web
- https://www.kobayashi.co.jp/
- Phone
- +81 662311144
- Auditors
- Ernst & Young ShinNihon LLC
Upcoming Events for 4967
Full Year 2024 Kobayashi Pharmaceutical Co Ltd Earnings Release
Kobayashi Pharmaceutical Co Ltd Annual Shareholders Meeting
Q1 2025 Kobayashi Pharmaceutical Co Ltd Earnings Release
Similar to 4967
AB&Company Co
Tokyo Stock Exchange
Adjuvant Holdings Co
Tokyo Stock Exchange
AIAI
Tokyo Stock Exchange
ALMADO
Tokyo Stock Exchange
Arata
Tokyo Stock Exchange
FAQ
What is the Kobayashi Pharmaceutical Co share price?
As of Today at 20:37 UTC, shares in Kobayashi Pharmaceutical Co are trading at ¥6,075. This share price information is delayed by 15 minutes.
How has the Kobayashi Pharmaceutical Co share price performed this year?
Shares in Kobayashi Pharmaceutical Co last closed at ¥6,075 and the price had moved by -7.45% over the past 365 days. In terms of relative price strength the Kobayashi Pharmaceutical Co share price has underperformed the Nikkei 225 Index by -22.5% over the past year.
What are the analyst and broker recommendations for Kobayashi Pharmaceutical Co?
The overall consensus recommendation for Kobayashi Pharmaceutical Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Kobayashi Pharmaceutical Co dividend yield?
The Kobayashi Pharmaceutical Co dividend yield is 1.66% based on the trailing twelve month period.
Does Kobayashi Pharmaceutical Co pay a dividend?
Last year, Kobayashi Pharmaceutical Co paid a total dividend of ¥101, and it currently has a trailing dividend yield of 1.66%.Looking ahead, shares in Kobayashi Pharmaceutical Co are due to go ex-dividend on 2024-12-27 and the next dividend pay date is 2025-03-01.
When does Kobayashi Pharmaceutical Co next pay dividends?
Kobayashi Pharmaceutical Co are due to go ex-dividend on 2024-12-27 and the next dividend pay date is 2025-03-01. The historic dividend yield on Kobayashi Pharmaceutical Co shares is currently 1.66%.
How do I buy Kobayashi Pharmaceutical Co shares?
To buy shares in Kobayashi Pharmaceutical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Kobayashi Pharmaceutical Co?
As of the previous close price of ¥6,075, shares in Kobayashi Pharmaceutical Co had a market capitalisation of ¥452bn.
Where are Kobayashi Pharmaceutical Co shares listed?
Here are the trading details for Kobayashi Pharmaceutical Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4967
What kind of share is Kobayashi Pharmaceutical Co?
Based on an overall assessment of its quality, value and momentum Kobayashi Pharmaceutical Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Kobayashi Pharmaceutical Co share price forecast for 2024?
The analyst consensus target price for shares in Kobayashi Pharmaceutical Co is ¥5,850. That is 3.7% below the last closing price of ¥6,075.
Analysts covering Kobayashi Pharmaceutical Co currently have a consensus Earnings Per Share (EPS) forecast of ¥147 for the next financial year.
Find out moreWhat is the trend in the Kobayashi Pharmaceutical Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Kobayashi Pharmaceutical Co. Over the past six months, its share price has outperformed the Nikkei 225 Index by +9.59%.
As of the last closing price of ¥6,075, shares in Kobayashi Pharmaceutical Co were trading +7.94% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Kobayashi Pharmaceutical Co PE Ratio?
The Kobayashi Pharmaceutical Co PE ratio based on its reported earnings over the past 12 months is 26.65. The shares last closed at ¥6,075.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Kobayashi Pharmaceutical Co?
Kobayashi Pharmaceutical Co's management team is headed by:
- Kazumasa Kobayashi - CHM
- Akihiro Kobayashi - PRE
- Noriaki Hirao - FID
- Satoshi Yamane - SMD
- Naoki Ayabe - MEO
- Fujito Ohwaki - MEO
- Atsushi Sato - DSL
- Jun Sato - DSL
- Kazuhito Miyanishi - EXO
- Takuya Matsushita - EXO
- Tetsushi Nishioka - EXO
- Yoshihiro Ogawa - EXO
- Nobuo Sakuta - EXO
- Kunio Ito - IND
- Kaori Sasaki - IND
- Haruo Tsuji - IND